Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced “Platelet Bridge”-Reference-Cited by-同舟云学术

Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced “Platelet Bridge”

Published:2021-05-27 Issue:22 Volume:13 Page:25701-25714
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Zhao Wei¹,Li Ting¹,Long Yang¹,Guo Rong¹,Sheng Qinglin¹,Lu Zhengze¹,Li Man¹,Li Jiaxin¹,Zang Shuya¹,Zhang Zhirong¹^ORCID,He Qin¹^ORCID

Affiliation:

1. Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy Sichuan University, Chengdu 610064, PR China

Funder

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.1c04442

Reference53 articles.

1. Nanoparticle therapeutics: an emerging treatment modality for cancer

2. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

3. Engineering precision nanoparticles for drug delivery